Diabetes

Disease State Hub

Multidisciplinary Roundtable: Diabetes

The Multidisciplinary Approach to Managing People With Diabetes, Guidelines for Care

In this video roundtable discussion, Carol Wysham, MD, interviews Eugene E. Wright, Jr., MD, and Hope Warshaw, MMSc, RD, CDCES, BC-ADM, about the multidisciplinary approach to managing people with diabetes and guidelines for care, including the value of utilizing the services of a certified diabetes care and education specialist, the pharmacologic approaches to managing patients with diabetes, and more.

Featured

Research Summary

Research Summary

AI-Based Insulin Decision System Matches Physician-Guided Therapy for Type 2 Diabetes

11/17/2025

Anthony Calabro, MA

A multicenter trial conducted in China found that an artificial intelligence–based insulin clinical decision support system provided glycemic outcomes comparable to standard therapy administered by senior...

11/17/2025

Multidisciplinary Roundtable

Multidisciplinary Roundtable

The Multidisciplinary Approach to Managing People With Diabetes, Guidelines for Care

11/12/2025

Carol Wysham, MD

11/12/2025

Expert Q&A

Expert Q&A

Targeting APOC3: A Potential New Tool for Managing Hypertriglyceridemia

11/10/2025

In this Consultant360 interview, Brian Bergmark, MD explains how olezarsen, an RNA-targeted therapy targeting APOC3, may help address residual cardiovascular risk in patients with moderate...

11/10/2025

Interactive Features

Slideshow

Slideshow

Consultant360’s Summer Playlist: Expert Perspectives on Emerging Clinical Issues

09/15/2025

As health care continues to evolve, staying current with expert perspectives is essential for clinical decision-making and patient care. This summer, Consultant360 engaged leading clinicians and thought...

09/15/2025

Clinical Insights

Multidisciplinary Roundtable

The Multidisciplinary Approach to Managing People With Diabetes, Guidelines for Care

11/12/2025

Carol Wysham, MD

11/12/2025

Expert Q&A

Targeting APOC3: A Potential New Tool for Managing Hypertriglyceridemia

11/10/2025

In this Consultant360 interview, Brian Bergmark, MD explains how olezarsen, an RNA-targeted therapy targeting APOC3, may help address residual cardiovascular risk in patients with moderate...

11/10/2025

ENDO 2025 Conference Coverage

Elangovan Krishnan, MBBS, PGDHM, M.Tech., MS, PhD

ENDO 2025 Conference Coverage

AI-Based Screening for Diabetic Retinopathy

07/21/2025

Elangovan Krishnan, MBBS, MS, PhD; Nancy Jayeshbhai Vora, MD; Gurudharshan Rajamani, MBBS; Ramya Elangovan; Kavin Elangovan

The team behind SMART, an AI-powered web application for diabetic retinopathy detection, discusses the development, validation, and clinical relevance of a lightweight, privacy-conscious screening model...

07/21/2025

Video

Video

Use of Diabetes Technologies and the Development of Diabetic Retinopathy in Patients With Type 1 Diabetes

07/02/2025

Risa M. Wolf, MD

In this video, Risa M. Wolf, MD, speaks about her team's study that examined the use of diabetes technologies—continuous glucose monitors (CGMs) and insulin pumps—and whether that was associated with the...

07/02/2025

ACP Internal Medicine Meeting 2025 Expert Q&A

ACP Internal Medicine Meeting 2025 Expert Q&A

The Ever-Changing Pharmacologic Landscape for Obesity Management

05/07/2025

Laura Davisson, MD, MPH, FACP

Laura Davisson, MD, MPH, FACP, professor of medicine, West Virginia University, discusses the rapidly evolving pharmacologic landscape for obesity management, including practical strategies for handling...

05/07/2025

Diabetes Snapshot

Reviewed by Kim Carmichael, MD

For more endocrinology content, visit the Resource Center.

Diabetes occurs when an individual has chronically elevated blood sugar levels, which may lead to adverse effects on the heart, eyes, and kidneys, among other organs.

For more endocrinology content, visit the Resource Center.

Diabetes is classified as type 1, in which an individual's pancreas produces little to no insulin, or type 2 diabetes, in which an individual's body becomes resistant to or does not produce enough insulin.

For more endocrinology content, visit the Resource Center.

Primary care providers, endocrinologists, ophthalmologists, optometrists, podiatrists, pharmacists, dieticians and nutritionists, certified diabetes care and education specialists, psychiatrists, psychologists, physical trainers

For more endocrinology content, visit the Resource Center.

Symptoms may include frequent urination, thirst, uncontrolled weight loss, hunger, blurred vision, numb/tingling hands or feet, fatigue, dry skin, sores, and an increased number of infections.

For more endocrinology content, visit the Resource Center.

Nausea, vomiting, and stomach pains are often symptoms of uncontrolled diabetes. People with type 2 diabetes may not have symptoms.

For more endocrinology content, visit the Resource Center.

An A1C test, fasting blood sugar test, glucose tolerance test, and random blood sugar test are all tools utilized to diagnose diabetes.

For more endocrinology content, visit the Resource Center.

More than 1 in 10 people in the United States have diabetes.
95% of people with diabetes have type 2 diabetes, while 5% have type 1 diabetes.

Research Summaries

Research Summary

AI-Based Insulin Decision System Matches Physician-Guided Therapy for Type 2 Diabetes

11/17/2025

Anthony Calabro, MA

11/17/2025

Public Health

Public Health

Trump Administration Reaches Deal with Eli Lilly, Novo Nordisk to Lower GLP-1 Weight-Loss Medication Costs

11/06/2025

Anthony Calabro, MA

The Trump administration announced a new agreement with pharmaceutical companies Eli Lilly and Company and Novo Nordisk to reduce the cost of obesity medication and expand access to these treatments.

11/06/2025

PUPC Conference Coverage

PUPC Conference Coverage

Navigating the Expanding Benefits and Long-Term Side Effects of GLP-1 Receptor Agonists

11/05/2025

Anthony Calabro, MA

As the clinical use of GLP-1 receptor agonists (RA) expands beyond diabetes and obesity, clinicians must balance emerging cardiometabolic and organ-specific benefits with the challenges of persistent...

11/05/2025

Research Summary

Once-Weekly Semaglutide Improves Glycemic Control and Weight in Adults With Type 1 Diabetes

11/05/2025

Kate Young

In adults with type 1 diabetes and obesity using automated insulin delivery, once-weekly semaglutide significantly improved time in range, lowered HbA1c, and reduced body weight by nearly 9 kg compared with...

11/05/2025

research summary

research summary

Is Dexamethasone Administration During Total Hip and Knee Arthroplasty Safe in Patients with Diabetes?

10/24/2025

Large-scale evidence shows perioperative dexamethasone reduces infection risk and shortens hospital stay in patients with diabetes undergoing joint arthroplasty, though hyperglycemia remains a concern. ...

10/24/2025

November 2025

Current Issue

November 2025

Sources: